Jeffrey B. Schwimmer

Jeffrey B. Schwimmer

Auto-generated profile, based on publicly available information

Jeffrey B. Schwimmer

Division of Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, University of California San Diego School of Medicine, La Jolla, California, USA

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 April 2003 in JAMA
Verified
Journal Article
Open access
PDF file
JSJeffrey B. Schwimmer
Jeffrey B. Schwimmer
TBTasha M. Burwinkle
Tasha M. Burwinkle
JVJames W. Varni
James W. Varni
Context: One in 7 US children and adolescents is obese, yet little is known about their health-related quality of life (QOL).Objective: To examine the health-related QOL of obese children and adolescents compared with children and adolescents who are healthy or those diagnosed as having cancer.Design, Setting, and Participants: Cross-sectional study of 106 children and adolescents (57 males) between the ages of 5 and 18 years (mean [SD], 12.1 [3] years), who had been referred to an academic children's hospital for evaluation of obesity between January and June 2002. Children and adolescents had a mean (SD) body mass index (BMI) of 34.7 (9.3) and BMI z score of 2.6 (0.5).Main Outcome Measures: Child self-report and parent proxy report using a pediatric QOL inventory generic core scale (range, 0-100). The inventory was administered by an interviewer for children aged 5 through 7 years. Scores were compared with previously published scores for healthy children and adolescents and children and adolescents diagnosed as having cancer.Results: Compared with healthy children and adolescents, obese children and adolescents reported significantly (P<.001) lower health-related QOL in all domains (mean [SD] total score, 67 [16.3] for obese children and adolescents; 83 [14.8] for healthy children and adolescents). Obese children and adolescents were more likely to have impaired health-related QOL than healthy children and adolescents (odds ratio [OR], 5.5; 95% confidence interval [CI], 3.4-8.7) and were similar to children and adolescents diagnosed as having cancer (OR, 1.3; 95% CI, 0.8-2.3). Children and adolescents with obstructive sleep apnea reported a significantly lower health-related QOL total score (mean [SD], 53.8 [13.3]) than obese children and adolescents without obstructive sleep apnea (mean [SD], 67.9 [16.2]). For parent proxy report, the child or adolescent's BMI z score was significantly inversely correlated with total score (r = −0.246; P = .01), physical functioning (r = −0.263; P<.01), social functioning (r = −0.347; P<.001), and psychosocial functioning (r = −0.209; P = .03).Conclusions: Severely obese children and adolescents have lower health-related QOL than children and adolescents who are healthy and similar QOL as those diagnosed as having cancer. Physicians, parents, and teachers need to be informed of the risk for impaired health-related QOL among obese children and adolescents to target interventions that could enhance health outcomes.

1 October 2006 in Pediatrics
Verified
Journal Article
Closed access
PDF file
JSJeffrey B. Schwimmer
Jeffrey B. Schwimmer
RDReena Deutsch
Reena Deutsch
TKTanaz Kahen
Tanaz Kahen
JLJoel E. Lavine
Joel E. Lavine
CSChristina Stanley
Christina Stanley
CBCynthia Behling
Cynthia Behling
OBJECTIVE. Fatty liver disease is diagnosed increasingly in children, but the prevalence remains unknown. We sought to determine the prevalence of pediatric fatty liver as diagnosed by histology in a population-based sample. METHODS. We conducted a retrospective review of 742 children between the ages of 2 and 19 years who had an autopsy performed by a county medical examiner from 1993 to 2003. Fatty liver was defined as ≥5% of hepatocytes containing macrovesicular fat. RESULTS. Fatty liver was present in 13% of subjects. For children and adolescents age 2 to 19 years, the prevalence of fatty liver adjusted for age, gender, race, and ethnicity is estimated to be 9.6%. Fatty liver prevalence increases with age, ranging from 0.7% for ages 2 to 4 up to 17.3% for ages 15 to 19 years. Fatty liver prevalence differs significantly by race and ethnicity (Asian: 10.2%; black: 1.5%; Hispanic: 11.8%; white: 8.6%). The highest rate of fatty liver was seen in obese children (38%). CONCLUSIONS. Fatty liver is the most common liver abnormality in children age 2 to 19 years. The presence of macrovesicular hepatic steatosis in ∼1 of every 10 children has important ramifications for the long-term health of children and young adults. The influence of the risk factors identified should be taken into consideration in the development of protocols designed to screen at-risk children and adolescents.

27 April 2011 in JAMA
Verified
Journal Article
Open access
PDF file
Joel Edward LavineJoel Edward Lavine
Joel Edward Lavine
JSJeffrey B. Schwimmer
Jeffrey B. Schwimmer
MNMark L. Van Natta
Mark L. Van Natta
JMJean P. Molleston
Jean P. Molleston
KMKaren F. Murray
Karen F. Murray
PRPatricia R. Robuck
Patricia R. Robuck
Coincident with the rise in prevalence of childhood and adolescent obesity over the past few decades, nonalcoholic fatty liver disease (NAFLD) has become the most common cause of chronic liver disease in children in the United States.1,2 NAFLD encompasses a range of severity from bland steatosis to nonalcoholic steatohepatitis (NASH) that may ultimately result in advanced fibrosis, cirrhosis, and hepatocellular carcinoma.3 Cirrhosis due to NAFLD has been described in children.4 Presence of NAFLD in children independently increases risks for cardiovascular disease.5

1 February 2017 in Journal of Pediatric Gastroenterology and Nutrition
Verified
Journal Article
Closed access
MVMiriam Vos
Miriam Vos
SAStephanie H. Abrams
Stephanie H. Abrams
SBSarah E. Barlow
Sarah E. Barlow
SCSonia Caprio
Sonia Caprio
SDStephen R. Daniels
Stephen R. Daniels
SXStavra A. Xanthakos
Stavra A. Xanthakos

22 August 2005 in Hepatology
Verified
Journal Article
Open access
PDF file
JSJeffrey B. Schwimmer
Jeffrey B. Schwimmer
CBCynthia Behling
Cynthia Behling
RNRobert Newbury
Robert Newbury
RDReena Deutsch
Reena Deutsch
CNCaroline Nievergelt
Caroline Nievergelt
JLJoel E. Lavine
Joel E. Lavine
Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) are common in children and adolescents. However, standard histological criteria for pediatric NAFLD and NASH are undeveloped. We reviewed consecutive patients ages 2 to 18 years with biopsy-proven NAFLD diagnosed between 1997 and 2003. Biopsies were evaluated by two pathologists for individual features of steatohepatitis. Agglomerative hierarchical cluster analysis demonstrated two different forms of steatohepatitis. Type 1 was characterized by steatosis, ballooning degeneration, and perisinusoidal fibrosis; type 2 was characterized by steatosis, portal inflammation, and portal fibrosis. The study included 100 children with NAFLD. Simple steatosis was present in 16% of subjects, and advanced fibrosis was present in 8%. Type 1 NASH was present in 17% of subjects, and type 2 NASH was present in 51%. Boys were significantly ( P < .01) more likely to have type 2 NASH and less likely to have type 1 NASH than girls. The NASH type differed significantly ( P < .001) by race and ethnicity. Type 1 NASH was more common in white children, whereas type 2 NASH was more common in children of Asian, Native American, and Hispanic ethnicity. In cases of advanced fibrosis, the pattern was generally that of type 2 NASH. In conclusion , type 1 and type 2 NASH are distinct subtypes of pediatric NAFLD, and type 2 is the most common pattern in children. NASH subtypes should be considered when interpreting liver biopsies and planning studies of the pathophysiology, genetics, natural history, or response to treatment in pediatric NAFLD. (Hepatology 2005;42:641–649.)

1 May 2013 in Radiology
Verified
Journal Article
Closed access
ATAn Tang
An Tang
JTJustin Tan
Justin Tan
MSMark Sun
Mark Sun
GHGavin Hamilton
Gavin Hamilton
MBMark Bydder
Mark Bydder
CSClaude B. Sirlin
Claude B. Sirlin
MR imaging with proton density fat fraction (PDFF) permitted high overall accuracy with moderate sensitivity and high specificity for classification of dichotomized steatosis grade, and these resul... PurposeTo evaluate the diagnostic performance of magnetic resonance (MR) imaging–estimated proton density fat fraction (PDFF) for assessing hepatic steatosis in nonalcoholic fatty liver disease (NA...